Nicholas Mort
Eli Lilly (United States)(US)
Publications by Year
Research Areas
TGF-β signaling in diseases, Angiogenesis and VEGF in Cancer, Cell Adhesion Molecules Research, Chemical Synthesis and Analysis, Hypothalamic control of reproductive hormones
Most-Cited Works
- → Synthesis and Activity of New Aryl- and Heteroaryl-Substituted Pyrazole Inhibitors of the Transforming Growth Factor-β Type I Receptor Kinase Domain(2003)237 cited
- → Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain(2004)162 cited
- → Kinetic Characterization of Novel Pyrazole TGF-β Receptor I Kinase Inhibitors and Their Blockade of the Epithelial−Mesenchymal Transition(2005)99 cited
- → Effect of N-methyl substitution of the peptide bonds in luteinizing hormone-releasing hormone agonists(1993)96 cited
- → The effect of NMeTyr5 substitution in luteinizing hormone-releasing hormone antagonists(1993)22 cited
- → Structure-activity relationships of positions 7, 8, and 9 in LHRH antagonists with respect to histamine release, LH, and testosterone suppressions(1994)